...
首页> 外文期刊>Future medicinal chemistry >Comparative evaluation of new dihydropyrimidine and dihydropyridine derivatives perturbing mitotic spindle formation
【24h】

Comparative evaluation of new dihydropyrimidine and dihydropyridine derivatives perturbing mitotic spindle formation

机译:新型二氢嘧啶和二氢吡啶衍生物扰动有丝分裂纺锤体形成的比较评价

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: The mitotic spindle plays a key role in cell division which makes it an important target in cancer therapy. In the present study the antiproliferative activity of 4-benzyl-5-phenyl-3,4-dihydropyrimidine-2(1 H )-thione ( 1 ) and its pyridine bioisoster ( 2 ) were evaluated and compared with monastrol (MON), the first known cell-permeable small molecule which disrupts bipolar spindle formation by inhibiting Eg5-kinesin?activity. Results: Our data revealed that compound 2 showed higher antiproliferative activity than MON against MCF7 and A375 cell lines and comparable reversible cell cycle inhibition in G2/M phase. However, compound 2 produced distinct phenotype from monoastral spindles, and did not affect Eg5 ATPase activity. Conclusion: The activity of compound 2 may suggest its new promising anticancer mechanism (different than MON), targeting other component required for spindle bipolarity.
机译:目的:有丝分裂主轴在细胞分裂中起着关键作用,这使其成为癌症治疗中的重要靶标。 在本研究中,评价4-苄基-5-苯基-3,4-二氢嘧啶-2(1H) - 硫嘧啶(1)及其吡啶Bioisoster(2)的抗增殖活性并与Monastrol(Mon)进行比较 首先已知的细胞可渗透的小分子,通过抑制EG5-kinesin来破坏双极主轴形成。活性。 结果:我们的数据显示,化合物2显示比MCF7和A375细胞系的常量抗增殖活动高于MCF7和A375细胞系,在G2 / M相中具有相当的可逆细胞周期抑制。 然而,化合物2从单坐锭子产生了不同的表型,并且不影响EG5 ATP酶活性。 结论:化合物2的活性可能表明其新的有前途的抗癌机制(不同于Mon),靶向主轴跨度所需的其他组分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号